Malignant hyperthermia and central core disease: disorders of Ca2+ release channels (Q34471672)

2 August 2017

1 reference

title

Malignant hyperthermia and central core disease: disorders of Ca2+ release channels (English)

1 reference

2 August 2017

malignant hyperthermia

1 reference

Loke J

1

1 reference

PubMed ID

9626031

2 August 2017

MacLennan DH

series ordinal

2

1 reference

PubMed ID

9626031

2 August 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

American Journal of Medicine

2 August 2017

1 reference

2 August 2017

104

1 reference

2 August 2017

5

1 reference

2 August 2017

470-486

1 reference

The mechanism of muscular contraction

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Control of muscle contraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Primary structure of the receptor for calcium channel blockers from skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Receptor sites for Ca2+ channel antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Voltage Dependent Charge Movement in Skeletal Muscle: a Possible Step in Excitation–Contraction Coupling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Involvement of dihydropyridine receptors in excitation–contraction coupling in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Charge movement and the nature of signal transduction in skeletal muscle excitation-contraction coupling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Normalization of current kinetics by interaction between the α1and β subunits of the skeletal muscle dihydropyridine-sensitive Ca2+ channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Acceleration of activation and inactivation by the β subunit of the skeletal muscle calcium channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Stereological analysis of mammalian skeletal muscle. II. White vastus muscle of the adult guinea pig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Stereological analysis of mammalian skeletal muscle. I. Soleus muscle of the adult guinea pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Biochemistry and biophysics of excitation-contraction coupling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Ryanodine receptor/Ca2+ release channels and their regulation by endogenous effectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Structure and function of ryanodine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Complex pharmacology of malignant hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Ryanodine receptor Ca2+ release channels: does diversity in form equal diversity in function?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Dantrolene, a Direct Acting Skeletal Muscle Relaxant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Inhibition of the intracellular release of calcium by Dantrolene in barnacle giant muscle fibres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Inhibitory action of dantrolene on Ca-induced Ca2+ release from sarcoplasmic reticulum in guinea pig skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Identification of a Mutation in Porcine Ryanodine Receptor Associated with Malignant Hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Primary structure and functional expression from cDNA of the cardiac ryanodine receptor/calcium release channel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Primary structure and distribution of a novel ryanodine receptor/calcium release channel from rabbit brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Structural evidence for direct interaction between the molecular components of the transverse tubule/sarcoplasmic reticulum junction in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Excitation-contraction coupling in vertebrate skeletal muscle: a tale of two calcium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Structure and function of voltage-dependent calcium channels from muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Biochemical evidence for a complex involving dihydropyridine receptor and ryanodine receptor in triad junctions of skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Co-expression in CHO cells of two muscle proteins involved in excitation-contraction coupling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Enhanced dihydropyridine receptor channel activity in the presence of ryanodine receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Cross-linking analysis of the ryanodine receptor and alpha1-dihydropyridine receptor in rabbit skeletal muscle triads.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Prolyl isomerases catalyze antibody folding in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

A novel FK506 binding protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Selective binding of FKBP12.6 by the cardiac ryanodine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Immunophilin Modulation of Calcium Channel Gating

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Amino acid sequence of rabbit fast-twitch skeletal muscle calsequestrin deduced from cDNA and peptide sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Molecular cloning and expression of cDNA encoding a lumenal calcium binding glycoprotein from sarcoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

The structure and interactions of Ca(2+)-ATPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Preparation and morphology of sarcoplasmic reticulum terminal cisternae from rabbit skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

The SERCA3-type of organellar Ca2+ pumps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

7 January 2021

Malignant hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

A mutation in the human ryanodine receptor gene associated with central core disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Myopathy caused by a deficiency of Ca2+-adenosine triphosphatase in sarcoplasmic reticulum (Brody's disease)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Mutations in the gene-encoding SERCA1, the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+ ATPase, are associated with Brody disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Phospholamban inhibitory function is activated by depolymerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Anaesthetic deaths in a family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Inheritance of malignant hyperpyrexia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Malignant hyperthermia: excitation-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Malignant hyperthermia: a statistical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Central-core disease and malignant hyperpyrexia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Anesthetic-induced malignant hyperpyrexia in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Malignant hyperthermia in Duchenne muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Masseter muscle rigidity associated with glycine1306-to-alanine mutation in the adult muscle sodium channel alpha-subunit gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Malignant hyperthermia in myotonia congenita

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Malignant hyperthermia: relationship to other diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Anesthetic complications in muscle disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Metabolic error of muscle metabolism after recovery from malignant hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Screening for Malignant Hyperpyrexia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Etiopathogenetic defect of malignant hyperthermia: hypersensitive calcium-release channel of skeletal muscle sarcoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Malignant hyperthermia--pearls out of swine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Changes underlying Halothane-induced Malignant Hyperpyrexia in Landrace Pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Porcine malignant hyperthermia: role of skeletal muscle in increased oxygen consumption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

SR function in malignant hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Calcium-induced Ca2+ release from sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia. The effects of halothane and dantrolene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Abnormal ryanodine receptor channels in malignant hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Reconstitution of abnormalities in the malignant hyperthermia-susceptible pig ryanodine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Abnormal human sarcoplasmic reticulum Ca2+ release channels in malignant hyperthermic skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Localization of the glucose phosphate isomerase gene to the p12----q21 segment of chromosome 6 in pig by in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Assignment of the porcine calcium release channel gene, a candidate for the malignant hyperthermia locus, to the 6p11----q21 segment of chromosome 6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Regional mapping of human chromosome 19: organization of genes for plasma lipid transport (APOC1, -C2, and -E and LDLR) and the genes C3, PEPD, and GPI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Cosegregation of porcine malignant hyperthermia and a probable causal mutation in the skeletal muscle ryanodine receptor gene in backcross families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Detection of a novel mutation at amino acid position 614 in the ryanodine receptor in malignant hyperthermia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

A cysteine-for-arginine substitution (R614C) in the human skeletal muscle calcium release channel cosegregates with malignant hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Alteration of intracellular Ca2+ transients in COS-7 cells transfected with the cDNA encoding skeletal-muscle ryanodine receptor carrying a mutation associated with malignant hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

RYR mutation G1021A (Gly341Arg) is not frequent in Danish and Swedish families with malignant hyperthermia susceptibility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

The substitution of Arg for Gly2433 in the human skeletal muscle ryanodine receptor is associated with malignant hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Phaeochromocytoma presenting as acute malignant hyperthermia--a diagnostic challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Masseter muscle spasm in children: implications of continuing the triggering anesthetic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

A clinical grading scale to predict malignant hyperthermia susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Should we use muscle biopsy to diagnose malignant hyperthermia susceptibility?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Retrospective analysis of anaesthetics received by patients before susceptibility to malignant hyperpyrexia was recognized

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Analysis of anaesthesia in patients suspected to be susceptible to malignant hyperthermia before diagnostic in vitro contracture test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Should we reassess the susceptibility of MH patients?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Estimation of test error rates, disease prevalence and relative risk from misclassified data: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Clinical presentation of suspected malignant hyperthermia during anaesthesia in 402 probands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Genetic effects on the variability of the halothane and caffeine muscle contracture tests.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Calmodulin sensitivity of the sarcoplasmic reticulum ryanodine receptor from normal and malignant-hyperthermia-susceptible muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

The structural organization of the human skeletal muscle ryanodine receptor (RYR1) gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Accelerated contractures after administration of ryanodine to skeletal muscle of malignant hyperthermia susceptible patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Comparison of in vitro contracture testing with ryanodine, halothane and caffeine in malignant hyperthermia and other neuromuscular disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

4-Chloro-m-cresol: a specific tool to distinguish between malignant hyperthermia-susceptible and normal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Chlorocresol, an additive to commercial succinylcholine, induces contracture of human malignant hyperthermia-susceptible muscles via activation of the ryanodine receptor Ca2+ channel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Changes in cytoplasmic free calcium caused by halothane. Role of the plasma membrane and intracellular Ca2+ stores.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Cytosolic free calcium concentrations in lymphocytes from malignant hyperthermia susceptible patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Importance of fasting in the lymphocyte calcium test for malignant hyperthermia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Erythrocyte membrane fluidity in malignant hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Evaluation of spin resonance spectroscopy of red blood cell membranes to detect malignant hyperthermia susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Non-invasive Evaluation of Maliganant Hyperthermia Susceptibility with Phosphorus Nuclear Magnetic Resonance Spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Metabolic response to exercise in malignant hyperthermia-sensitive patients measured by 31P magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

In vitro correlation between force and energy metabolism in porcine malignant hyperthermic muscle studied by 31P NMR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

A blinded comparison of noninvasive, in vivo phosphorus nuclear magnetic resonance spectroscopy and the in vitro halothane/caffeine contracture test in the evaluation of malignant hyperthermia susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Improved noninvasive diagnostic testing for malignant hyperthermia susceptibility from a combination of metabolites determined in vivo with 31P-magnetic resonance spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

[Definition of a diagnostic score of malignant hyperthermia using P-31 magnetic resonance spectroscopy]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

[Prospective evaluation of a nuclear magnetic resonance score in the screening of malignant hyperthermia susceptibility. Initial results]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Clinical reassessment of malignant hyperthermia in Abitibi-Témiscamingue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17q

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Adult muscle sodium channel alpha-subunit is a gene candidate for malignant hyperthermia susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Genetic mapping of the beta 1- and gamma-subunits of the human skeletal muscle L-type voltage-dependent calcium channel on chromosome 17q and exclusion as candidate genes for malignant hyperthermia susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Exclusion of malignant hyperthermia susceptibility (MHS) from a putative MHS2 locus on chromosome 17q and of the alpha 1, beta 1, and gamma subunits of the dihydropyridine receptor calcium channel as candidates for the molecular defect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Localization of the gene encoding the alpha 2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

A genome wide search for susceptibility loci in three European malignant hyperthermia pedigrees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

A calcium channel mutation causing hypokalemic periodic paralysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Skeletal muscle DHP receptor mutations alter calcium currents in human hypokalaemic periodic paralysis myotubes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Oxidative enzymes and phosphorylase in central-core disease of muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Central core disease: ultrastructure of the sarcoplasmic reticulum and T-tubules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Evidence for linkage of the central core disease locus to the proximal long arm of human chromosome 19.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

The ligand binding site and transduction mechanism in the inositol-1,4,5-triphosphate receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Structure-function relationships of the mouse inositol 1,4,5-trisphosphate receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Intracellular calcium homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Mitochondrial calcium overload: A general mechanism for cell-necrosis in muscle diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Identification of heterozygous and homozygous individuals with the novel RYR1 mutation Cys35Arg in a large kindred.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel Tyr to Ser mutation in a pedigree with associated central cores

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Detection of a novel mutation in the ryanodine receptor gene in an Irish malignant hyperthermia pedigree: correlation of the IVCT response with the affected and unaffected haplotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Detection of a novel RYR1 mutation in four malignant hyperthermia pedigrees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Novel mutations at a CpG dinucleotide in the ryanodine receptor in malignant hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Porcine malignant hyperthermia carrier detection and chromosomal assignment using a linked probe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

7 January 2021

Prediction of the halothane (Hal) genotypes of pigs by deducing Hal, Phi, Po2, Pgd haplotypes of parents and offspring: results from a large-scale practice in Swedish breeds.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

7 January 2021

Discordance between phenotype and genotype in malignant hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

7 January 2021

Enhanced mobilization of intracellular Ca2+ induced by halothane in hepatocytes isolated from swine susceptible to malignant hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900108-9

7 January 2021

10.1016/S0002-9343(98)00108-9

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

9626031